Status:

UNKNOWN

Electroacupuncture Combined With Umbilical Moxibustion on Abdominal Obesity of Yang Deficiency

Lead Sponsor:

Hubei Hospital of Traditional Chinese Medicine

Conditions:

Obesity, Abdominal

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

Obesity is a chronic metabolic disease that seriously harms human health, while abdominal obesity is more closely related to diseases such as type 2 diabetes, cardiovascular disease, and tumors, and h...

Eligibility Criteria

Inclusion

  • 1\. People who meet the following diagnostic criteria and are diagnosed with abdominal obesity due to yang deficiency:
  • Diagnostic criteria for abdominal obesity: Refer to the criteria in the "Guidelines for the Comprehensive Medical Management of Obese People" jointly issued by the American Academy of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) in May 2016: male waist circumference ≥85cm, female Waist circumference ≥80cm can be diagnosed as abdominal obesity.
  • Yang Deficiency Quality Criteria: Meet the diagnostic criteria of Yang Deficiency in the "Classification and Judgment Table of Traditional Chinese Medicine Constitution". Common manifestations are chills, cold limbs, swollen face, pale complexion, pale tongue, white slippery fur, and weak pulse.
  • 2\. Age: 18 to 55 years old; 3. Sign the informed consent and voluntarily accept the intervention method of this project.

Exclusion

  • Severe lung, heart, liver, kidney and other diseases;
  • Combined endocrine diseases (polycystic ovary syndrome, hypothyroidism, Cushing syndrome, etc.);
  • Have a history of surgery to lose weight; have a history of adhesions after previous surgery;
  • Have taken drugs that are known to affect weight or appetite in the past 3 months, such as weight loss drugs, corticosteroids, etc.; have used hormone drugs, lipid-lowering drugs, and hypoglycemic drugs in the past 3 months;
  • Women during pregnancy, lactation and menopause;
  • Participated in clinical research on weight loss in the past 3 months; Those who meet any of the above will be excluded from the study.

Key Trial Info

Start Date :

April 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 31 2022

Estimated Enrollment :

68 Patients enrolled

Trial Details

Trial ID

NCT04835181

Start Date

April 1 2021

End Date

January 31 2022

Last Update

April 8 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.